Sarah Gilbert, who is a professor of vaccinology at the University of Oxford in the UK and a leading scientist at the university’s Jenner Institute, has outlined to the media her team’s plans to advance a vaccine using recombinant DNA techniques to create a SARS-CoV-2 antigen and embedding it within a primate adenovirus vector. She expressed the hope and aim of having a viable anti-COVID-19 product “available for global use” by September.
Gilbert’s team of experts was awarded a £2.2m grant from the UK’s National Institute for Health Research and the UK...







![Spotlight On RDCs, AOCs As Leading Novel Bioconjugates[Updated]](https://web.insights.norstella-labs.com/resizer/v2/3M7ZAWZOBNK7NG4A4WDOIFG6DU.jpg?smart=true&auth=392a1fdb3cfacb29445720c412410e598dbcc5f90f14857652cd498bd0faa0fb&width=400&height=225)